查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1888691

靜脈輸液市場規模、佔有率和趨勢分析報告：按類型、營養成分、最終用途、地區和細分市場預測（2025-2033 年）

Intravenous Solutions Market Size, Share & Trends Analysis Report By Type, By Nutrients, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

靜脈輸液市場摘要

全球靜脈輸液市場預計到 2024 年將價值 128 億美元，到 2033 年將達到 282 億美元。

預計從 2025 年到 2033 年，該行業將以 9.4% 的複合年成長率成長。這一成長是由神經系統疾病、胃腸道疾病和癌症等疾病的日益普遍所驅動的。

靜脈輸液提供必需的營養素和主要能源來源。已開發國家（如美國和英國）早產率的上升進一步推動了靜脈輸液的需求。這些國家擁有先進的新生兒護理基礎設施，並高度依賴靜脈輸液治療。孕婦年齡偏大、輔助生殖技術（ART）的普及以及孕婦慢性疾病（如糖尿病和高血壓）等因素，都導致了這些國家早產兒數量的增加。例如，根據Tommy's報道，英格蘭和威爾斯的早產率從2021年的7.5%上升到2022年的7.9%，連續第二年成長。 2022年，超過53,000名嬰兒早產。

營養不良是推動靜脈輸液市場發展的主要因素之一。根據世界衛生組織（WHO）預測，到2022年，全球將有25億成年人超重，其中8.9億人肥胖，3.9億人體重不足。全球範圍內，1.49億五歲以下兒童發育遲緩，4,500萬兒童體重不足，3,700萬名兒童超重或肥胖。全球範圍內如此高的營養不良盛行率正在推動市場成長。聯合國兒童基金會（UNICEF）指出，嬰兒出生後1000天內的營養不良會導致認知能力下降和發育遲緩。嬰兒的飲食應包含澱粉、礦物質、維生素、胺基酸、脂質和其他關鍵營養素。這些必需營養素可以透過腸外營養（或孤兒營養）補充，預計這將有助於市場擴張。大量需要這些營養素的營養不良和早產兒預計也將進一步推動市場成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析

第4章 靜脈輸液市場：按類型分類的估算與趨勢分析

  • 按類型分類的市佔率變化分析（2024 年和 2033 年）
  • 按類型分類的市場規模、預測和趨勢分析（2021年至2033年）
  • 全靜脈營養
  • 周邊靜脈營養

第5章 靜脈輸液市場：依營養成分分類的估算與趨勢分析

  • 按營養素分類的市佔率變化分析（2024 年和 2033 年）
  • 按營養成分分類的市場規模、預測與趨勢分析（2021年至2033年）
  • 碳水化合物
  • 維生素和礦物質
  • 單劑量胺基酸
  • 腸外脂肪乳劑
  • 其他

第6章 靜脈輸液市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市佔率變化分析（2024 年和 2033 年）
  • 按最終用途分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 家
  • 醫院
  • 點滴中心

第7章 靜脈輸液市場：區域估算與趨勢分析

  • 區域市場概覽
  • 區域市場：主要結論
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與企業概況
  • 企業市場分析/企業市場占有率分析（2024）
  • 公司分類
  • 策略規劃
  • 公司簡介/列表
    • Fresenius Kabi AG
    • B. Braun SE
    • Baxter
    • Otsuka Pharmaceutical Co., Ltd.
    • Pfizer, Inc.
    • JW Life Science
    • Vifor Pharma
    • ICU Medical, Inc.
Product Code: GVR-1-68038-137-5

Intravenous Solutions Market Summary

The global intravenous solutions market size was valued at USD 12.80 billion in 2024 and is expected to reach USD 28.2 billion by 2033, growing at a CAGR of 9.4% from 2025 to 2033. This growth is attributed to the increasing prevalence of diseases, such as neurological diseases, gastrointestinal diseases, and cancer.

IV solutions provide essential nutrients and are a main source of energy. The rising rates of premature births in developed countries such as the U.S. and the UK are further fueling the demand for intravenous (IV) solutions, as these nations have advanced neonatal care infrastructure that relies heavily on IV therapy. In these countries, factors such as increasing maternal age, higher rates of assisted reproductive technologies (ART), and chronic maternal conditions such as diabetes and hypertension have contributed to a growing number of preterm deliveries. For instance, according to Tommy's, the premature birth rate in England and Wales rose to 7.9% in 2022, up from 7.5% in 2021, marking two consecutive years of increase. Over 53,000 babies were born prematurely in 2022.

Malnutrition is one of the major drivers of the Intravenous (IV) solution market. According to the WHO, in 2022, 2.5 billion adults were overweight, with 890 million living with obesity, while 390 million were underweight. Globally, 149 million children under 5 were stunted, 45 million were wasted, and 37 million were overweight or obese. This high prevalence of malnutrition globally contributes to market growth. According to UNICEF, poor nutrition in the first 1,000 days of an infant's life may lead to impaired cognitive ability and stunted growth. Starch, minerals, vitamins, amino acids, lipids, and other key substances must be present in an infant's diet. These essential nutrients can be administered through parenteral nutrition, which is expected to boost the market. A high number of malnourished children and premature neonates that require these nutrients is expected to further propel the market.

Global Intravenous Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous solutions market report based on type, nutrient, end use and regions:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition
  • Nutrients Outlook (Revenue, USD Million, 2021 - 2033)
  • Carbohydrates
  • Vitamins & Minerals
  • Single-dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Home
  • Hospitals
  • Infusion Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Nutrient
    • 1.2.3. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Number of Premature Births
      • 3.2.1.2. Increasing Incidence of Cancer
      • 3.2.1.3. Increasing Risk of Malnutrition
      • 3.2.1.4. Growing Geriatric Population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Shortage of Parenteral Nutrition Products
      • 3.2.2.2. Increased Use of Enteral Nutrition
      • 3.2.2.3. High Risk of Infections
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Regulatory Framework
      • 3.2.5.1. Standards and Compliances
        • 3.2.5.1.1. North America
        • 3.2.5.1.2. Europe
        • 3.2.5.1.3. Asia Pacific
        • 3.2.5.1.4. Latin America
        • 3.2.5.1.5. MEA
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Intravenous Solutions Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Type Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (Revenue USD Million)
  • 4.4. Total Parenteral Nutrition
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 4.5. Peripheral Parenteral Nutrition
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)

Chapter 5. Intravenous Solutions Market: Nutrient Estimates & Trend Analysis

  • 5.1. Nutrient Segment Dashboard
  • 5.2. Nutrient Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Nutrient, 2021 to 2033 (Revenue USD Million)
  • 5.4. Carbohydrates
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 5.5. Vitamins & Minerals
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 5.6. Single-dose Amino Acids
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 5.7. Parenteral Lipid Emulsion
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 5.8. Others
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)

Chapter 6. Intravenous Solutions Market: End Use Estimates & Trend Analysis

  • 6.1. End use Segment Dashboard
  • 6.2. End use Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (Revenue USD Million)
  • 6.4. Home
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 6.5. Hospitals
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
  • 6.6. Infusion Centers
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)

Chapter 7. Intravenous Solutions Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market: Key Takeaways
  • 7.3. North America
    • 7.3.1. North America Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamic
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive insights
      • 7.3.2.4. U.S. Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamic
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive insights
      • 7.3.3.4. Canada Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamic
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive insights
      • 7.3.4.4. Mexico Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamic
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive insights
      • 7.4.2.4. Germany Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamic
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive insights
      • 7.4.3.4. UK Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamic
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive insights
      • 7.4.4.4. France Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamic
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive insights
      • 7.4.5.4. Italy Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamic
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive insights
      • 7.4.6.4. Spain Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamic
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive insights
      • 7.4.7.4. Denmark Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamic
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Competitive insights
      • 7.4.8.4. Sweden Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamic
      • 7.4.9.2. Regulatory framework
      • 7.4.9.3. Competitive insights
      • 7.4.9.4. Norway Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamic
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive insights
      • 7.5.2.4. Japan Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamic
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive insights
      • 7.5.3.4. China Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamic
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive insights
      • 7.5.4.4. India Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamic
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive insights
      • 7.5.5.4. South Korea Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamic
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive insights
      • 7.5.6.4. Australia Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamic
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive insights
      • 7.5.7.4. Thailand Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Intravenous Solutions Market Estimates and Forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamic
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive insights
      • 7.6.2.4. Brazil Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamic
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive insights
      • 7.6.3.4. Argentina Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
  • 7.7. MEA
    • 7.7.1. MEA Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamic
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive insights
      • 7.7.2.4. South Africa Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamic
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive insights
      • 7.7.3.4. Saudi Arabia Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamic
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive insights
      • 7.7.4.4. UAE Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamic
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive insights
      • 7.7.5.4. Kuwait Intravenous Solutions market estimates and forecasts, 2021 - 2033 (Revenue USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis/Company Market Share Analysis, (2024)
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. Fresenius Kabi AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. B. Braun SE
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Baxter
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Otsuka Pharmaceutical Co., Ltd.
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Pfizer, Inc.
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. JW Life Science
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Vifor Pharma
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. ICU Medical, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviation
  • Table 2. List of secondary data sources
  • Table 3. North America Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 4. North America Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 5. North America Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 6. North America Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 7. U.S. Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 8. U.S. Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 9. U.S. Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 10. Canada Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 11. Canada Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 12. Canada Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 13. Mexico Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 14. Mexico Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 15. Mexico Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 16. Europe Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 17. Europe Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 18. Europe Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 19. Europe Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 20. Germany Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 21. Germany Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 22. Germany Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 23. Germany Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 24. U.K. Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 25. U.K. Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 26. U.K. Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 27. France Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 28. France Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 29. France Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 30. Italy Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 31. Italy Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 32. Italy Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 33. Spain Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 34. Spain Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 35. Spain Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 36. Sweden Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 37. Sweden Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 38. Sweden Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 39. Denmark Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 40. Denmark Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 41. Denmark Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 42. Norway Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 43. Norway Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 44. Norway Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 45. Asia Pacific Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 46. Asia Pacific Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 47. Asia Pacific Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 48. Asia Pacific Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 49. China Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 50. China Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 51. China Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 52. Japan Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 53. Japan Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 54. Japan Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 55. India Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 56. India Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 57. India Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 58. Australia Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 59. Australia Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 60. Australia Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 61. Thailand Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 62. Thailand Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 63. Thailand Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 64. South Korea Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 65. South Korea Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 66. South Korea Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 67. Latin America Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 68. Latin America Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 69. Latin America Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 70. Latin America Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 71. Brazil Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 72. Brazil Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 73. Brazil Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 74. Argentina Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 75. Argentina Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 76. Argentina Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 77. MEA Intravenous Solutions market, by country, 2021 - 2033 (Revenue USD Million)
  • Table 78. MEA Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 79. MEA Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 80. MEA Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 81. South Africa Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 82. South Africa Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 83. South Africa Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 84. Saudi Arabia Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 85. Saudi Arabia Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 86. Saudi Arabia Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 87. UAE Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 88. UAE Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 89. UAE Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)
  • Table 90. Kuwait Intravenous Solutions market, by type, 2021 - 2033 (Revenue USD Million)
  • Table 91. Kuwait Intravenous Solutions market, by nutrient, 2021 - 2033 (Revenue USD Million)
  • Table 92. Kuwait Intravenous Solutions market, by end use, 2021 - 2033 (Revenue USD Million)

List of Figures

  • Fig. 1 Intravenous solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape
  • Fig. 12 Intravenous solutions market dynamics
  • Fig. 13 Intravenous solutions market: PORTER's analysis
  • Fig. 14 Intravenous solutions market: PESTEL analysis
  • Fig. 15 Intravenous solutions market by type: key takeaways
  • Fig. 16 Intravenous solutions market, by type: market share, 2024 & 2033
  • Fig. 17 Total parenteral nutrition market, 2021 - 2033 (Revenue USD Million)
  • Fig. 18 Peripheral parenteral nutrition market, 2021 - 2033 (Revenue USD Million)
  • Fig. 19 Intravenous solutions market, by end-use: key takeaways
  • Fig. 20 Intravenous solutions market, by nutrients: market share, 2024 & 2033
  • Fig. 21 Carbohydrates market, 2021 - 2033 (Revenue USD Million)
  • Fig. 22 Single dose amino acid solution market, 2021 - 2033 (Revenue USD Million)
  • Fig. 23 Vitamins and minerals, 2021 - 2033 (Revenue USD Million)
  • Fig. 24 Parenteral lipid emulsion, 2021 - 2033 (Revenue USD Million)
  • Fig. 25 Others market, 2021 - 2033 (Revenue USD Million)
  • Fig. 26 Intravenous solutions market by end use: key takeaways
  • Fig. 27 Intravenous solutions market, by end use: market share, 2024 & 2033
  • Fig. 28 Home market, 2021 - 2033 (Revenue USD Million)
  • Fig. 29 Hospitals market, 2021 - 2033 (Revenue USD Million)
  • Fig. 30 Infusion Centers market, 2021 - 2033 (Revenue USD Million)
  • Fig. 31 Intravenous solutions market revenue, by region, 2024 & 2033 (Revenue USD Million)
  • Fig. 32 Regional marketplace: key takeaways
  • Fig. 33 Regional marketplace: key takeaways
  • Fig. 34 North America intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 US intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 39 Europe intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Italy intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Spain intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 56 Asia Pacific intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 69 Latin America intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Mexico intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Brazil intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 76 MEA intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait intravenous solutions market, 2021 - 2033 (Revenue USD Million)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis
  • Fig. 87 Company market share/position analysis, 2024
  • Fig. 88 Strategy mapping